Metformin targets histone acetylation in cancer-prone epithelial cells
Open Access
- 23 November 2016
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 15 (24) , 3355-3361
Abstract
The usage of metabolic intermediates as substrates for chromatin-modifying enzymes provides a direct link between the metabolic state of the cell and epigenetics. Because this metabolism-epigenetics axis can regulate not only normal but also diseased states, it is reasonable to suggest that manipulating the epigenome via metabolic interventions may improve the clinical manifestation of age-related diseases including cancer. Using a model of BRCA1 haploinsufficiency-driven accelerated geroncogenesis, we recently tested the hypothesis that: 1.) metabolic rewiring of the mitochondrial biosynthetic nodes that overproduce epigenetic metabolites such as acetyl-CoA should promote cancer-related acetylation of histone H3 marks; 2.) metformin-induced restriction of mitochondrial biosynthetic capacity should manifest in the epigenetic regulation of histone acetylation. We now provide one of the first examples of how metformin-driven metabolic shifts such as reduction of the 2-carbon epigenetic substrate acetyl-CoA is sufficient to correct specific histone H3 acetylation marks in cancer-prone human epithelial cells. The ability of metformin to regulate mitonuclear communication and modulate the epigenetic landscape in genomically unstable pre-cancerous cells might guide the development of new metabolo-epigenetic strategies for cancer prevention and therapy.Keywords
This publication has 66 references indexed in Scilit:
- PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and TumorigenesisCell, 2012
- Metabolic Regulation of EpigeneticsCell Metabolism, 2012
- Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsGenes & Development, 2012
- IDH mutation impairs histone demethylation and results in a block to cell differentiationNature, 2012
- Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth GenesMolecular Cell, 2011
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationCancer Cell, 2010
- p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in MammalsJournal of Biological Chemistry, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Histone modifications at human enhancers reflect global cell-type-specific gene expressionNature, 2009
- CBP/p300-mediated acetylation of histone H3 on lysine 56Nature, 2009